1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Lymphocyte Count: new trials by email Literature Review of Lymphocyte Count trials Research Report on Lymphocyte Count
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies Rituximab, Cyclophosphamide, Fludarabine - Leukemia, Lymphoma | Phase 1 | Terminated | M.D. Anderson Cancer Center | 4 | 2007-05-01 | 2011-12-19 |
Graft vs Host Disease (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma (1) · Neoplasms, Plasma Cell (1)
M.D. Anderson Cancer Center (1)
United States (1)